Effects of drugs on the efficacy of radioiodine (131I) therapy in hyperthyroid patients

被引：10

作者：

Oszukowska, Lidia ^{[2
]}

Knapska-Kucharska, Malgorzata ^{[2
]}

Lewinski, Andrzej ^{[1
,3
]}

机构：

[1] Med Univ Lodz, Dept Endocrinol & Metab Dis, PL-93338 Lodz, Poland

[2] Med Univ Lodz, Dept Nucl Med & Oncol Endocrinol, PL-93338 Lodz, Poland

[3] Polish Mothers Mem Hosp Res Inst, Lodz, Poland

来源：

ARCHIVES OF MEDICAL SCIENCE | 2010年 / 6卷 / 01期

关键词：

hyperthyroidism; medical treatment; (I-131) radioiodine therapy; GRAVES-DISEASE; RADIOACTIVE IODINE; THIONAMIDE WITHDRAWAL; ANTITHYROID DRUGS; CURE RATE; CARBIMAZOLE; PROPYLTHIOURACIL; GLUCOCORTICOIDS; OPHTHALMOPATHY; CONTROVERSIES;

D O I：

10.5114/aoms.2010.13499

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The treatment of hyperthyroidism is targeted at reducing the production of thyroid hormones by inhibiting their synthesis or suppressing their release, as well as by controlling their influence on peripheral tissue (conservative therapy, medical treatment) Radical treatment includes surgical intervention to reduce the volume of thyroid tissue or damage of the mechanisms of thyroid hormone synthesis by radioiodine (I-131) administration Radioiodine (I-131) is a reactor radionuclide, produced as a result of uranium decomposition and emission of beta and gamma radiation The therapeutic effects of the isotope are obtained by the emission of p radiation In the paper, the effects of administered drugs (antithyroid, glucocorticosteroids, lithium carbonate, inorganic iodine, beta-blockers) on the final outcome of radioiodine therapy in patients with hyperthyroidism are discussed.

引用

页码：4 / 10

页数：7

共 50 条

[21] 131I therapy of thyroid cancer patients
Reiners, C
Farahati, J
QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 1999, 43 (04): : 324 - 335
[22] 131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma
Gabriel Castro
Isabel Berrocal
Jaime Carmona
Javiera González
Patricio González
European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 1356 - 1357
[23] The efficiency of planning of therapeutic 131I activities in the radioiodine therapy of differentiated thyroid cancer
Sinyuta, B
Dzhuzha, D
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1004 - 1004
[24] Radioiodine (131I) therapy in a child with autism spectrum disorder: A complex and demanding task
Bibbo, Giovanni
Kirkwood, Ian
Sigalas, Victoria
Benger, Tracy
WORLD JOURNAL OF NUCLEAR MEDICINE, 2019, 18 (03) : 293 - 295
[25] 131I Radioiodine therapy in Graves' disease: Us et coutumes, controversies and guidelines
Bardet, S.
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2020, 44 (04): : 267 - 271
[26] Pretherapeutic uptake of 131I does not predict outcome after radioiodine therapy for hyperthyroidism
Becherer, A.
Kessler, H.
Boehler, T.
Furlan, W.
Hofmann, A.
Karakolcu, F.
Wiederin, H.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S539 - S539
[27] Exhalation of 131I after radioiodine therapy:: Time dependence and chemical form.
Schomaecker, K
Fischer, T
Gaidouk, M
Schicha, H
JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 251P - 251P
[28] Improving 131I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nanoparticles
Le Goas, Marine
Paquet, Marie
Paquirissamy, Aurelie
Guglielmi, Julien
Compin, Cathy
Thariat, Juliette
Vassaux, Georges
Geertsen, Valerie
Humbert, Olivier
Renault, Jean-Philippe
Carrot, Geraldine
Pourcher, Thierry
Cambien, Beatrice
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 : 7933 - 7946
[29] Transient cytotoxicity of 131I beta radiation in hyperthyroid patients treated with radioactive iodine
Sundaram, P. Shanmuga
Padma, S.
Sudha, S.
Sasikala, K.
INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 133 (04) : 401 - 406
[30] HYPOTHYROIDISM AND 131I THERAPY
ELLIS, F
BRITISH MEDICAL JOURNAL, 1968, 3 (5613): : 314 - &

← 1 2 3 4 5 →